Caissa Capital Management ltd., 10% Owner at Avalo Therapeutics, Inc. (AVTX), bought 25,000 shares at $2.79 ($69K) on 2023-05-04, disclosed to the SEC on 2023-05-08.
Open-market purchase of $69k AVTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.79 | 15,000 | $42K | 60.3% |
| 2 | $2.88 | 5,000 | $14K | 20.8% |
| 3 | $2.62 | 5,000 | $13K | 18.9% |
| Total | $2.77 avg | 25,000 | $69K | 100% |
| Filing → |
| AVTX | BUY | 2023-06-14 | $64K | — | Filing → |
| AVTX | BUY | 2023-06-09 | $56K | — | Filing → |
| AVTX | BUY | 2023-06-02 | $2K | — | Filing → |